Page 132 - Merck Sharp News Today

KUALA LUMPUR, Oct 11 — The Health Ministry should not be so quick to dismiss cheaper and more readily available options to treat Covid-19 in the long term, Kuala Kedah MP Dr Azman Ismail said today. The Opposition lawmaker said that while new, innovative drugs like the antiviral Molnupiravir...

Phamac will be supplied with 60,000 courses of the pill if approved by Medsafe.

Business Scoop provides news and views on Business and Markets from New Zealand

PETALING JAYA: The antiviral drug Molnupiravir will not replace vaccines but will offer an alternative in treating Covid-19 patients, health experts have pointed out.

Scoop Community provides New Zealand Community news and views

SEREMBAN: The Health Ministry will consider buying other antiviral medicines to treat Covid-19 patients other than molnupiravir, says Health Minister Khairy Jamaluddin.

Pharmac has negotiated an agreement with supplier Merck Sharp & Dohme (MSD) to purchase the antiviral molnupiravir

KUALA LUMPUR: A detailed explanation must be given as to why the government decided to procure the antiviral medicine Molnupiravir for Covid-19 treatment, says Datuk Seri Dr Ahmad Zahid Hamidi.

The Drug Control Authority and the National Pharmaceutical Regulatory Agency (NPRA) must do their due diligence and carefully evaluate the safety profile of Molnupiravir.  Experts say this is especially important in view of the drug’s small sample size in clinical trials.  Malaysian Medical Association (MMA) president Dr Koh Kar Chai said any drug that is to be registered, even if only conditionally approved, will need to have undergone due diligence to ensure an acceptable level...

SEREMBAN: The Health Ministry will consider buying other antiviral medicines to treat Covid-19 patients other than Molnupiravir, says Health Minister Khairy Jamaluddin.